title: RAG-1 and Ly6D independently reflect progression in the B lymphoid lineage.
abstract: Common lymphoid progenitors (CLPs) are thought to represent major intermediates in the transition of hematopoietic stem cells (HSCs) to B lineage lymphocytes. However, it has been obvious for some time that CLPs are heterogeneous, and there has been controversy concerning their differentiation potential. We have now resolved four Flt3(+) CLP subsets that are relatively homogenous and capable of forming B cells. Differentiation potential and gene expression patterns suggest Flt3(+) CLPs lacking both Ly6D and RAG-1 are the least differentiated. In addition to B cells, they generate natural killer (NK) and dendritic cells (DCs). At the other extreme is a subset of the recently described Flt3(+) Ly6D(+) CLPs that have a history of RAG-1 expression and are B lineage restricted. These relatively abundant and potent CLPs were depleted within 48 hours of acute in vivo estrogen elevation, suggesting they descend from hormone regulated progenitors. This contrasts with the hormone insensitivity of other CLP subsets that include NK lineage progenitors. This progenitor heterogeneity and differentiation complexity may add flexibility in response to environmental changes. Expression of RAG-1 and display of Ly6D are both milestone events, but they are neither synchronized nor dependent on each other.
authors.affiliation: Immunobiology & Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States of America.
authors.forename: Qingzhao
authors.initials: Q
authors.lastname: Zhang
authors.forename: Brandt L
authors.initials: BL
authors.lastname: Esplin
authors.forename: Ryuji
authors.initials: R
authors.lastname: Iida
authors.forename: Karla P
authors.initials: KP
authors.lastname: Garrett
authors.forename: Zhixin L
authors.initials: ZL
authors.lastname: Huang
authors.forename: Kay L
authors.initials: KL
authors.lastname: Medina
authors.forename: Paul W
authors.initials: PW
authors.lastname: Kincade
mesh_terms: D000818:Animals; D000950:Antigens, Ly / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects / Q000276:immunology; D019070:Cell Lineage / Q000187:drug effects / Q000276:immunology*; D004967:Estrogens / Q000494:pharmacology; D058851:GPI-Linked Proteins / Q000378:metabolism; D018398:Homeodomain Proteins / Q000378:metabolism*; D018655:Lymphocyte Count; D016131:Lymphocyte Subsets / Q000166:cytology / Q000276:immunology; D038041:Lymphopoiesis / Q000187:drug effects / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D054448:Precursor Cells, B-Lymphoid / Q000166:cytology* / Q000187:drug effects / Q000276:immunology*; D013256:Steroids / Q000494:pharmacology
chemical_list: D000950:Antigens, Ly; D004967:Estrogens; D058851:GPI-Linked Proteins; D018398:Homeodomain Proteins; C035271:Ly6d protein, mouse; D013256:Steroids; C064658:RAG-1 protein
references.citation: J Exp Med. 2007 Oct 29;204(11):2561-8
references.pmid: 17923504
references.citation: Nat Immunol. 2003 Sep;4(9):866-73
references.pmid: 12925850
references.citation: Blood. 2006 Oct 15;108(8):2531-9
references.pmid: 16809609
references.citation: Blood. 2011 Mar 3;117(9):2618-24
references.pmid: 21163922
references.citation: Blood. 2006 Mar 15;107(6):2311-6
references.pmid: 16291588
references.citation: Blood. 2011 Aug 4;118(5):1283-90
references.pmid: 21652681
references.citation: Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5382-6
references.pmid: 8202495
references.citation: Nat Immunol. 2001 Aug;2(8):718-24
references.pmid: 11477408
references.citation: Blood. 2008 Aug 15;112(4):1048-55
references.pmid: 18495958
references.citation: Genes Dev. 2009 Oct 15;23(20):2376-81
references.pmid: 19833765
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5925-30
references.pmid: 20231472
references.citation: Blood. 2011 Sep 8;118(10):2723-32
references.pmid: 21791413
references.citation: Blood. 2008 Jun 15;111(12):5562-70
references.pmid: 18424665
references.citation: J Exp Med. 2006 Mar 20;203(3):675-87
references.pmid: 16505143
references.citation: Blood. 2009 Jan 22;113(4):807-15
references.pmid: 18927436
references.citation: PLoS One. 2010 Sep 23;5(9):e12954
references.pmid: 20886092
references.citation: Immunol Rev. 2010 Nov;238(1):12-22
references.pmid: 20969581
references.citation: Cell. 2005 Apr 22;121(2):295-306
references.pmid: 15851035
references.citation: Blood. 2012 Nov 1;120(18):3688-98
references.pmid: 22927250
references.citation: Cell Stem Cell. 2012 Mar 2;10(3):273-83
references.pmid: 22385655
references.citation: J Immunol. 2005 Oct 15;175(8):4858-65
references.pmid: 16210587
references.citation: Nat Immunol. 2006 Mar;7(3):293-301
references.pmid: 16429139
references.citation: Leukemia. 2007 Feb;21(2):311-9
references.pmid: 17170726
references.citation: J Immunol. 2008 Nov 1;181(9):6061-72
references.pmid: 18941195
references.citation: Proc Natl Acad Sci U S A. 2011 May 3;108(18):7517-22
references.pmid: 21502490
references.citation: Cell Stem Cell. 2007 Aug 16;1(2):218-29
references.pmid: 18371352
references.citation: Cell. 1997 Nov 28;91(5):661-72
references.pmid: 9393859
references.citation: Immunity. 2002 Dec;17(6):749-56
references.pmid: 12479821
references.citation: Blood. 2001 May 1;97(9):2708-15
references.pmid: 11313262
references.citation: J Immunol. 2008 Dec 1;181(11):7514-24
references.pmid: 19017941
references.citation: J Immunol. 2009 Dec 15;183(12):7768-77
references.pmid: 20007571
references.citation: J Immunol. 2012 Oct 15;189(8):3822-30
references.pmid: 22972921
references.citation: J Exp Med. 2004 Feb 16;199(4):491-502
references.pmid: 14769852
references.citation: Immunity. 2010 Mar 26;32(3):426-36
references.pmid: 20303297
references.citation: Immunity. 2007 Apr;26(4):407-19
references.pmid: 17433729
references.citation: Blood. 2010 Mar 11;115(10):1897-905
references.pmid: 19965655
references.citation: J Immunol. 2001 Aug 1;167(3):1387-92
references.pmid: 11466357
references.citation: Blood. 2010 Mar 11;115(10):1906-12
references.pmid: 20040757
references.citation: Immunity. 2002 Aug;17(2):117-30
references.pmid: 12196284
references.citation: Blood. 2011 May 19;117(20):5449-52
references.pmid: 21422472
references.citation: Blood. 1993 Dec 1;82(11):3327-32
references.pmid: 8241503
references.citation: J Exp Med. 2006 Aug 7;203(8):1867-73
references.pmid: 16880261
references.citation: J Immunol. 2007 Feb 15;178(4):2008-17
references.pmid: 17277104
references.citation: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6311-6
references.pmid: 17404232
references.citation: Immunity. 2007 Jun;26(6):703-14
references.pmid: 17582343
references.citation: Curr Opin Immunol. 2012 Apr;24(2):196-203
references.pmid: 22236696
references.citation: J Immunol. 2008 Dec 1;181(11):7507-13
references.pmid: 19017940
references.citation: Blood. 1999 Jul 15;94(2):713-23
references.pmid: 10397738
references.citation: J Immunol. 2008 Jan 1;180(1):138-45
references.pmid: 18097013
references.citation: Blood. 2010 Apr 1;115(13):2601-9
references.pmid: 19996414
references.citation: Blood. 2002 Nov 15;100(10):3672-80
references.pmid: 12393656
references.citation: J Exp Med. 2007 Oct 29;204(11):2569-78
references.pmid: 17923507
references.citation: Immunity. 2003 Sep;19(3):365-75
references.pmid: 14499112
references.citation: Blood. 2001 Jun 15;97(12):3683-90
references.pmid: 11389003
references.citation: Blood. 2011 Nov 17;118(20):5439-47
references.pmid: 21931117
references.citation: Curr Protoc Immunol. 2005 May;Chapter 22:Unit 22F.3
references.pmid: 18432950